PYXS

$0.00

(

0.00%

)
Quote details

stock

Pyxis Oncology Inc

NASDAQ | PYXS

3.23

USD

$0.00

(

0.00%

)

At Close (As of Oct 14, 2025)

$213.96M

Market Cap

-

P/E Ratio

-1.59

EPS

$5.39

52 Week High

$0.83

52 Week Low

HEALTHCARE

Sector

PYXS Chart

Recent Chart
Price Action

PYXS Technicals

Tags:

PYXS Earnings

Earnings Performance

PYXS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $157M
Total Current Assets $132M
Cash And Cash Equivalents At Carrying Value $19M
Cash And Short Term Investments $19M
Inventory -
Current Net Receivables -
Total Non Current Assets $25M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $2.6M
Intangible Assets Excluding Goodwill $2.6M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $107M
Other Current Assets $5.5M
Other Non Current Assets -
Total Liabilities $36M
Total Current Liabilities $18M
Current Accounts Payable $4.9M
Deferred Revenue -
Current Debt -
Short Term Debt $2.9M
Total Non Current Liabilities $19M
Capital Lease Obligations $20M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $20M
Other Current Liabilities $9.9M
Other Non Current Liabilities -
Total Shareholder Equity $121M
Treasury Stock -
Retained Earnings -$364M
Common Stock $60K
Common Stock Shares Outstanding $58M

PYXS News

PYXS Profile

Pyxis Oncology Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Pyxis Oncology, Inc. is a preclinical biotechnology firm based in Cambridge, Massachusetts, focused on advancing innovative therapies for cancer treatment through the development of antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs). With a commitment to harnessing the power of targeted therapies, Pyxis aims to enhance the efficacy and safety profiles of oncology treatments, addressing unmet medical needs in the oncology landscape. The company's cutting-edge research and strategic partnerships position it for potential breakthroughs in cancer therapy.

VHAI
+66.66%
$0.00
YYAI
-11.76%
$0.15
BURU
-20.39%
$0.40
UGRO
+54.52%
$0.57
NVDA
-4.40%
$180.03
CGBS
-39.47%
$0.03
PLUG
+3.84%
$4.05
BITF
+28.33%
$5.39
NVTS
+26.07%
$12.57
TMQ
+59.90%
$10.49
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.57%
$3.19
LAES
+24.79%
$7.65
INTC
-4.27%
$35.63
BYND
-24.56%
$0.78
JOBY
+8.05%
$18.12
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.05%
$0.34
F
+1.08%
$11.66
EDHL
+114.42%
$1.07
CRML
+28.73%
$29.97
WULF
+10.42%
$15.46
ACHR
+1.91%
$13.01
SOUN
+8.98%
$20.86
BBD
+1.94%
$3.15
NAK
+4.13%
$2.76
TLRY
-5.32%
$1.60
DVLT
+24.76%
$2.12
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
QBTS
+6.00%
$43.06
GPUS
-5.58%
$0.40
TSLA
-1.52%
$429.24
MARA
+9.88%
$22.24
AMD
+0.77%
$218.09
SOFI
+2.68%
$27.87
AXDX
-61.36%
$0.03
MNTS
+19.58%
$1.71
CLF
+0.94%
$13.96
QS
+15.57%
$16.98
ERIC
+20.56%
$9.85
RIG
-2.65%
$3.11
ETHD
+6.60%
$3.55
CIFR
+2.70%
$20.89
NIO
-5.15%
$6.81
QUBT
+1.49%
$21.78
NUAI
+30.63%
$3.07
UAMY
+4.54%
$17.47
NOK
+4.28%
$5.47
CLSK
+9.68%
$21.98
ASST
-7.69%
$0.99
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
IREN
+8.16%
$69.37
AREC
+36.74%
$6.81
ADAP
-11.16%
$0.16
ABAT
+36.59%
$9.22
RF
+2.44%
$25.16
BTG
+0.56%
$5.34
JDZG
+59.57%
$3.00
WWR
+35.93%
$3.48
AAL
+1.90%
$11.74
USAR
-2.72%
$37.62
UUUU
+16.86%
$23.77
PFE
-0.82%
$24.52
BAC
+2.45%
$50.06
SNAP
-1.61%
$7.92
BMNR
-6.84%
$52.96
RMBL
+60.50%
$3.21
MP
+3.77%
$98.65
AMZN
-1.69%
$216.34
T
+2.11%
$26.13
ADD
-25.47%
$0.05
BCRX
-8.80%
$6.42
JBLU
+7.91%
$4.91
WFC
+7.14%
$84.56
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
ATXS
+37.07%
$11.61
HPE
+0.80%
$25.00
AQMS
+198.89%
$29.62
IONQ
-5.53%
$77.55
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDLY
-7.78%
$0.78
VALE
-0.36%
$10.97
C
+3.89%
$99.84
KDP
+2.32%
$26.42
RGTZ
-5.37%
$8.80
GRAB
-0.33%
$5.91
HOOD
-4.07%
$134.94
BULL
-0.08%
$11.73
GWH
-16.24%
$7.58
DFLI
-2.54%
$1.53
ABEV
+1.16%
$2.16
NB
+3.09%
$11.67
VHAI
+66.66%
$0.00
YYAI
-11.76%
$0.15
BURU
-20.39%
$0.40
UGRO
+54.52%
$0.57
NVDA
-4.40%
$180.03
CGBS
-39.47%
$0.03
PLUG
+3.84%
$4.05
BITF
+28.33%
$5.39
NVTS
+26.07%
$12.57
TMQ
+59.90%
$10.49
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.57%
$3.19
LAES
+24.79%
$7.65
INTC
-4.27%
$35.63
BYND
-24.56%
$0.78
JOBY
+8.05%
$18.12
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.05%
$0.34
F
+1.08%
$11.66
EDHL
+114.42%
$1.07
CRML
+28.73%
$29.97
WULF
+10.42%
$15.46
ACHR
+1.91%
$13.01
SOUN
+8.98%
$20.86
BBD
+1.94%
$3.15
NAK
+4.13%
$2.76
TLRY
-5.32%
$1.60
DVLT
+24.76%
$2.12
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
QBTS
+6.00%
$43.06
GPUS
-5.58%
$0.40
TSLA
-1.52%
$429.24
MARA
+9.88%
$22.24
AMD
+0.77%
$218.09
SOFI
+2.68%
$27.87
AXDX
-61.36%
$0.03
MNTS
+19.58%
$1.71
CLF
+0.94%
$13.96
QS
+15.57%
$16.98
ERIC
+20.56%
$9.85
RIG
-2.65%
$3.11
ETHD
+6.60%
$3.55
CIFR
+2.70%
$20.89
NIO
-5.15%
$6.81
QUBT
+1.49%
$21.78
NUAI
+30.63%
$3.07
UAMY
+4.54%
$17.47
NOK
+4.28%
$5.47
CLSK
+9.68%
$21.98
ASST
-7.69%
$0.99
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
IREN
+8.16%
$69.37
AREC
+36.74%
$6.81
ADAP
-11.16%
$0.16
ABAT
+36.59%
$9.22
RF
+2.44%
$25.16
BTG
+0.56%
$5.34
JDZG
+59.57%
$3.00
WWR
+35.93%
$3.48
AAL
+1.90%
$11.74
USAR
-2.72%
$37.62
UUUU
+16.86%
$23.77
PFE
-0.82%
$24.52
BAC
+2.45%
$50.06
SNAP
-1.61%
$7.92
BMNR
-6.84%
$52.96
RMBL
+60.50%
$3.21
MP
+3.77%
$98.65
AMZN
-1.69%
$216.34
T
+2.11%
$26.13
ADD
-25.47%
$0.05
BCRX
-8.80%
$6.42
JBLU
+7.91%
$4.91
WFC
+7.14%
$84.56
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
ATXS
+37.07%
$11.61
HPE
+0.80%
$25.00
AQMS
+198.89%
$29.62
IONQ
-5.53%
$77.55
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDLY
-7.78%
$0.78
VALE
-0.36%
$10.97
C
+3.89%
$99.84
KDP
+2.32%
$26.42
RGTZ
-5.37%
$8.80
GRAB
-0.33%
$5.91
HOOD
-4.07%
$134.94
BULL
-0.08%
$11.73
GWH
-16.24%
$7.58
DFLI
-2.54%
$1.53
ABEV
+1.16%
$2.16
NB
+3.09%
$11.67

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.